Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000912282-25-001013
Filing Date
2025-10-01
Accepted
2025-10-01 17:32:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6645
2 JOINT FILING AGREEMENT agm.htm EX-1.01 3732
  Complete submission text file 0000912282-25-001013.txt   12017
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Subject) CIK: 0001611747 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-89384 | Film No.: 251365738
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1200 BRICKELL AVENUE, #1470 MIAMI FL 33131
Business Address
STONE DANIEL E. (Filed by) CIK: 0001948744 (see all company filings)

Type: SCHEDULE 13G/A